In the last trading session, 1.55 million shares of the Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) were traded, and its beta was 0.25. Most recently the company’s share price was $2.09, and it changed around -$0.07 or -3.24% from the last close, which brings the market valuation of the company to $532.23M. MRVI currently trades at a discount to its 52-week high of $10.03, offering almost -379.9% off that amount. The share price’s 52-week low was $1.66, which indicates that the current value has risen by an impressive 20.57% since then. We note from Maravai LifeSciences Holdings Inc’s average daily trading volume that its 10-day average is 1.48 million shares, with the 3-month average coming to 2.36 million.
Maravai LifeSciences Holdings Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 7 recommended MRVI as a Hold, whereas 5 deemed it a Buy, and 1 rated it as Underweight.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) trade information
Instantly MRVI has showed a red trend with a performance of -3.24% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.35 on recent trading dayincreased the stock’s daily price by 11.06%. The company’s shares are currently down -61.65% year-to-date, but still down -3.24% over the last five days. On the other hand, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) is -0.48% down in the 30-day period. We can see from the shorts that 13.67 million shares have been sold at a short interest cover period of 7.36 day(s).
The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 58.2% from its current value. Analyst projections state that MRVI is forecast to be at a low of $5 and a high of $5.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -64.27%. Maravai LifeSciences Holdings Inc earnings are expected to increase by -182.83% in 2025, but the outlook is negative -26.41% per year for the next five years.
MRVI Dividends
Maravai LifeSciences Holdings Inc’s next quarterly earnings report is expected to be released on 2025-May-11.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.68% of Maravai LifeSciences Holdings Inc shares, and 89.91% of them are in the hands of institutional investors. The stock currently has a share float of 99.55%. Maravai LifeSciences Holdings Inc stock is held by 256.0 institutions, with GTCR LLC being the largest institutional investor. By 2024-06-30, it held 14.8334% of the shares, which is about 20.15 million shares worth $144.27 million.
12 WEST CAPITAL MANAGEMENT LP, with 9.7254% or 13.21 million shares worth $94.59 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
